Daily Archives: March 13, 2016

Enrichment design accommodating the biomarker misclassification

Increased understanding of the mechanistic heterogeneity of diseases has brought us to the era of molecularly targeted therapies (MTAs) in clinical oncology. The MTAs block the growth of cancer cells by identifying and attacking specific biomarker pathways

Life on sulfur. Why we need complete genomes

The ability of bacteria to grow on inorganic compounds like sulfur was discovered by Russian microbiologist Sergey Winogradskij in 1888. First, he studied a sulfur bacterium of the Beggiatoaceae family to demonstrate that it can produce energy

Inventing an new flap for small to medium-sized defects of the knee

Coverage of soft tissue defects of the knee due to multiple operations, trauma and infection remains a surgical challenge. Often these defects are repaired using free tissue transfer. The aim of the current study was to find

OCT provides a better understanding about retinal damage in two rare neuromuscular diseases

The facial – scapular – humeral muscular dystrophy (FSHD) and myotonic dystrophy type 1 (DM1) are neuromuscular diseases with systemic clinical manifestations. Although rare, they are genetic myopathies most frequently encountered in adults. The diagnosis is confirmed

Medical products from human blood plasma in Scotland

A number of important medical products are obtained from human blood plasma; these fall into three main categories: –  Immunoglobulins (antibodies) for treating disorders of immunity or certain infections, as well as for preventing rhesus disease of